Washington Drug Letter
Sept. 24, 2012
| Vol.
44 No.
38
House Passes Generic User Fee Fix, Allowing FDA to Collect Fees
The House late Wednesday passed a fix that would allow the FDA to begin collecting the generic user fees authorized by the FDA Safety and Innovation Act.
This article is viewable by subscribers only. To view this article, please select an option below.
|